Name: Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni (Video) | JoVE Journal
Uploaded: 2018-01-14T13:00:00.000+00:00
Duration: 12 min 5 s
Description: Learn mass isolation and in vitro cultivation of Schistosoma mansoni miracidia using a mouse model. This protocol enables large-scale larval harvesting for advancing schistosomiasis research and disease control.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Funded in part by NIH grant RO1AI015503. Schistosome-infected mice were provided by the NIAID Schistosomiasis Resource Center at the Biomedical Research Institute (Rockville, MD) through NIH-NIAID Contract HHSN272201000005I for distribution through BEI Resources.

All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison under Protocol no. V005717. The following protocol involves working in a Biosafety Level 2 (BSL2) facility for human pathogens, although none of the schistosome stages depicted in this protocol are infective to humans or other mammals. Follow institutional policies for handling Risk Group 2 (RG2) human pathogens.
NOTE: We use female Swiss-Webster mice (6-week old) due to their higher susceptibility to infection10, thereby yielding larger egg burdens. Tucker et al. describe the mouse and snail infection protocols used in this model system11. The Table of Materials lists all of the specific equipment, materials, reagents and animal sources needed to carry out this experimental protocol.
1. Processing of infected livers
<ol>
	<li>Euthanize mice, 6-7 weeks post-infection, by CO2 asphyxiation (rate of 10-30% of the chamber&#39;s volume per minute). Monitor mice for cessation of respiration and heartbeat. 
	NOTE: Typically, up to 20 mice may be processed at a given time.</li>
	<li>After transferring euthanized mice to a biosafety cabinet, place mice on their backs and spray their ventral surfaces with 70% ethanol. Let soak for 1 min.</li>
	<li>Pinch and pull up skin of the lower abdomen and cut across the base of the pinched skin closest to the abdomen with sterile surgical scissors. Pull the cut skin anteriorly (i.e., toward the head) to reveal the liver. Note that the liver should be enlarged and speckled due to an egg-induced granulomatous response (Figure 2A).</li>
	<li>Remove the liver and place it in a beaker containing 200 mL of sterile 1.2% NaCl solution containing pen/strep.</li>
	<li>Repeat steps 1.3 and 1.4 with remaining mice. 
	NOTE: Twenty mice are usually processed in a single harvest.</li>
	<li>Place the livers in a sterile Petri dish and remove non-liver fat/connective tissues with sterile forceps.</li>
	<li>Transfer trimmed/cleaned livers to a sterile 250-mL centrifuge bottle containing ~200 mL of sterile 1.2% NaCl solution with pen/strep.</li>
	<li>Vigorously shake the bottle containing the livers and, using a sterile disposable pipette, remove the excess surface foam/floating debris. Slowly pour off the remaining saline solution into a container or sink containing 1% bleach (disinfectant).</li>
	<li>Add ~200 mL of fresh saline solution to the livers and repeat step 1.8 three more times.</li>
</ol>
2. Liver extraction and miracidial isolation
<ol>
	<li>Place the livers into a small sterile stainless-steel blender cup and add ~2 mL of 1.2% NaCl solution (Figure 2B).</li>
	<li>Cover the cup with foil and a petri dish to prevent spills, and blend for 1 min by alternating low and high speed (20 s low speed/10 s high speed; repeat) (Figure 2C).</li>
	<li>Evenly distribute the blended liver suspension into sterile 250-mL centrifuge bottles (for 20 livers use 4 bottles).</li>
	<li>Add sterile saline with antibiotics to ~200 mL total volume/bottle. Weigh/balance bottles prior to centrifugation.</li>
	<li>Centrifuge the blended livers at 290 x g for 15 min at 4 oC. Gently pour off supernatants into a container with bleach prior to discarding.</li>
	<li>Repeat steps 2.4-2.5 once. Be sure to thoroughly resuspend liver sediment prior to centrifugation.</li>
	<li>After discarding the last saline wash (Step 2.6), add 200 mL sterile pond water with pen/strep to the pelleted liver tissue, shake to resuspend sediment, and transfer the suspension to a sterilized 1-L volumetric flask that has been completely covered with aluminum foil, except for the top 3 cm of the neck (Figure 2D). 
	NOTE: Use two bottles (= 10 livers) per 1-L flask. Pond water simulates the natural freshwater environment needed to stimulate miracidial hatching from eggs.</li>
	<li>Using sterile pond water, fill up the flask to approximately 3 cm above the foil covering on neck. Then, without delay (as miracidia soon begin to hatch), remove residual foam and liver tissue floating to the surface by quickly pipetting up ~12 mL of pond water containing debris and discarding it into a separate discard tube. Replace with fresh sterile pond water.</li>
	<li>Repeat cleaning Step 2.8, three more times, checking for presence of miracidia in the discard tube. Cease repetition of cleaning step if miracidia appear in the wash solution.</li>
	<li>After the last wash, slowly add ~12 mL of warm sterile pond water (pre-warmed to 30 oC) to create a temperature gradient with clean, sterile warm water on top. 
	NOTE: This is best accomplished by slowly discharging water along the side of the flask neck to avoid mixing.</li>
	<li>Place a small Petri dish cover over the flask opening and shine a bright light across the top of the flask above the foil cover to illuminate the upper surface of water. 
	NOTE: Typically, within 5-10 min, swimming miracidia, attracted to the light, will concentrate in large numbers within the first 2-3 cm of pond water (Figure 3A).</li>
</ol>
3. Miracidial harvesting and cultivation
<ol>
	<li>When miracidia have amassed at the surface after 10 min, using a sterile transfer pipet, remove ~8 mL of pond water and transfer to a sterile 15-mL centrifuge tube. Place the tube containing miracidia on ice.</li>
	<li>Add back 8 mL of warm sterile pond water along the inside of the volumetric flask and wait another 10 min.</li>
	<li>Using new tubes each time, repeat steps 3.1 and 3.2 three more times. After the 4th collection, keep the final tube on ice for 10 min to allow the miracidia to settle. This set of tubes comprises the first harvest.</li>
	<li>Centrifuge tubes containing miracidia at 290 x g for 1 min at 4 oC in a pre-cooled refrigerated centrifuge.</li>
	<li>Immediately remove most of the supernatant (~7 mL) being careful not to disturb the parasite pellet (Figure 3B).</li>
	<li>Pool all the miracidia from this first harvest into one tube, then rinse all of the original tubes with ~1 mL sterile pond water and add to the &#34;pooled&#34; tube.</li>
	<li>Allow parasites to settle on ice for ~5 min, and again centrifuge the parasites at 290 x g for 1 min at 4 oC.</li>
	<li>Carefully remove the supernatant and add 6-8 mL sterile Chernin&#39;s balanced salt solution (CBSS+; see Table of Materials) containing pen/strep.</li>
	<li>Gently suspend the miracidia and aliquot them into a 24-well culture plate (1 mL per well), followed by rinsing the tube in 6-8 mL CBSS+ and adding 1 mL of rinse to each well. Incubate parasites at 26 oC under normoxic conditions. Concentrations of isolated miracidia will vary, but will usually average ~7000/mL.</li>
	<li>If parasites are still concentrating at the light source, repeat Steps 3.1 to 3.9 to continue harvesting late-hatching miracidia but increase the time interval between collections to 15-20 min. 
	NOTE: This new set of tubes represents the second harvest. However, because miracidial numbers typically are low, larvae from all tubes usually are pooled into a single culture well containing 2 mL CBSS+.</li>
	<li>At 24 h post-harvest and cultivation, gently resuspend sporocysts in their wells by pipetting.</li>
	<li>Wait a few min to allow parasites to settle to the bottom of the wells. Once they have settled, carefully remove the supernatant (~1.5 mL), which will contain most of the ciliated epidermal plates shed by miracidia during larval transformation. This &#34;transformation&#34; supernatant may either be discarded or incorporated into follow-up studies of larval secretory products.</li>
	<li>Add 1.5 mL of fresh CBSS+ to each well and gently pipette to resuspend sporocysts. Repeat step 3.12 if further washing or changing to a different medium is desired.</li>
</ol>

<ol><li>Colley, D. G., Bustinduy, A. L., Secor, W. E., King, C. H. <a target="_blank" href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61949-2/abstract">Human schistosomiasis.</a> Lancet. 383, 2253-2264 (2014).</li>
<li>WHO. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Schistosomiasis%3A+number+of+people+treated+worldwide+in+2013%5BTitle%5D)+AND+%22Wkly.+Epidemiol.+Rec%22%5BJournal%5D)">Schistosomiasis: number of people treated worldwide in 2013.</a> Wkly. Epidemiol. Rec. 5 (90), 25-32 (2015).</li>
<li>Yoshino, T. P., Gourbal, B., Théron, A. Schistosoma sporocysts. <a target="_blank" href="https://www.routledge.com/Schistosoma-Biology-Pathology-and-Control/Jamieson/p/book/9781498744256">Schistosoma: biology, pathology and control</a>. Jamieson, B. G. M. , CRC Press. Boca Raton. 118-148 (2017).</li>
<li>Bayne, C. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Successful+parasitism+of+vector+snail+Biomphalaria+glabrata+by+the+human+blood+fluke+%28trematode%29+Schistosoma+mansoni%3A+a+2009+assessment%5BTitle%5D)+AND+%22Mol.+Biochem.+Parasitol%22%5BJournal%5D)">Successful parasitism of vector snail Biomphalaria glabrata by the human blood fluke (trematode) Schistosoma mansoni: a 2009 assessment.</a> Mol. Biochem. Parasitol. 165 (1), 8-18 (2009).</li>
<li>Yoshino, T. P., Coustau, C. Immunobiology of Biomphalaria-trematode interactions. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aYoshino%2C+TP+%22Biomphalaria+snails+and+larval+trematodes%22">Biomphalaria snails and larval trematodes</a>. Toledo, R., Fried, B. , Springer. New York. 159-189 (2011).</li>
<li>Coustau, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Advances+in+gastropod+immunity+from+the+study+of+the+interaction+between+the+snail+Biomphalaria+glabrata+and+its+parasites%3A+A+review+of+research+progress+over+the+last+decade%5BTitle%5D)+AND+%22Fish+Shellfish+Immunol%22%5BJournal%5D)">Advances in gastropod immunity from the study of the interaction between the snail Biomphalaria glabrata and its parasites: A review of research progress over the last decade.</a> Fish Shellfish Immunol. 46 (1), 5-16 (2015).</li>
<li>Bayne, C. J., Hahn, U. K., Bender, R. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanisms+of+molluscan+host+resistance+and+of+parasite+strategies+for+survival%5BTitle%5D)+AND+%22Parasitology%22%5BJournal%5D)">Mechanisms of molluscan host resistance and of parasite strategies for survival.</a> Parasitology. 123, S159-S167 (2001).</li>
<li>McMullen, D. B., Beaver, P. C. <a target="_blank" href="https://www.cabdirect.org/cabdirect/abstract/19462900219">Studies on schistosome dermatitis. IX. The life cycles of three dermatitis-producing schistosomes from birds and a discussion of the subfamily Bilharziellinae (Trematoda: Schistosomatidae).</a> Amer. J. Hyg. 42, 128-154 (1945).</li>
<li>Voge, M., Seidel, J. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transformation+in+vitro+of+miracidia+of+Schistosoma+mansoni+and+S.+japonicum+into+young+sprocysts%5BTitle%5D)+AND+%22J.+Parasitol%22%5BJournal%5D)">Transformation in vitro of miracidia of Schistosoma mansoni and S. japonicum into young sprocysts.</a> J. Parasitol. 58 (4), 699-704 (1972).</li>
<li>Eloi-Santos, S., Olsen, N. J., Correa-Oliveira, R., Colley, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Schistosoma+mansoni%3A+mortality%2C+pathophysiology%2C+and+susceptibility+differences+in+male+and+female+mice%5BTitle%5D)+AND+%22Exp.+Parasitol%22%5BJournal%5D)">Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice.</a> Exp. Parasitol. 75 (2), 168-175 (1992).</li>
<li>Tucker, M. S., Karunaratne, L. B., Lewis, F. A., Freitas, T. C., Liang, Y. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Schistosomiasis%5BTitle%5D)+AND+%22Curr+Proto+Immunol%22%5BJournal%5D)">Schistosomiasis.</a> Curr Proto Immunol. 103, 19.1:19.1.1-19.1.58 (2013).</li>
<li>Basch, P. F., DiConza, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+miracidium-sporocyst+transition+in+Schistosoma+mansoni%3A+surface+changes+in+vitro+with+ultrastructural+correlation%5BTitle%5D)+AND+%22J.+Parasitol%22%5BJournal%5D)">The miracidium-sporocyst transition in Schistosoma mansoni: surface changes in vitro with ultrastructural correlation.</a> J. Parasitol. 60 (6), 935-941 (1974).</li>
<li>Hansen, E. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Secondary+daughter+sporocysts+of+Schistosoma+mansoni%3A+their+occurrence+and+cultivation%5BTitle%5D)+AND+%22Ann.+N.+Y.+Acad.+Sci%22%5BJournal%5D)">Secondary daughter sporocysts of Schistosoma mansoni: their occurrence and cultivation.</a> Ann. N. Y. Acad. Sci. 266, 426-436 (1975).</li>
<li>Stibbs, H. H., Owczarzak, O., Bayne, C. J., DeWan, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Schistosome+sporocyst-killing+amoebae+Isolated+from+Biomphalaria+glabrata%5BTitle%5D)+AND+%22J.+Invertebr.+Pathol%22%5BJournal%5D)">Schistosome sporocyst-killing amoebae Isolated from Biomphalaria glabrata.</a> J. Invertebr. Pathol. 33, 159-170 (1979).</li>
<li>DiConza, J. J., Basch, P. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Axenic+cultivation+of+Schistosoma+mansoni+daughter+sporocysts%5BTitle%5D)+AND+%22J.+Parasitol%22%5BJournal%5D)">Axenic cultivation of Schistosoma mansoni daughter sporocysts.</a> J. Parasitol. 60 (5), 757-763 (1974).</li>
<li>Hansen, E. L. A cell line from embryos of Biomphalaria glabrata (Pulmonata): Establishment and characteristics. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aHansen%2C+EL+%22Invertebrate+tissue+culture%3A+Research+applications%22">Invertebrate tissue culture: Research applications</a>. Maramorosch, K. , Academic Press. New York. 75-97 (1976).</li>
<li>Yoshino, T. P., Laursen, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Production+of+Schistosoma+mansoni+daughter+sporocysts+from+mother+sporocysts+maintained+in+synxenic+culture+with+Biomphalaria+glabrata+embryonic+%28Bge%29+cells%5BTitle%5D)+AND+%22J.+Parasitol%22%5BJournal%5D)">Production of Schistosoma mansoni daughter sporocysts from mother sporocysts maintained in synxenic culture with Biomphalaria glabrata embryonic (Bge) cells.</a> J. Parasitol. 81 (5), 714-722 (1995).</li>
<li>Ivanchenko, M. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Continuous+in+vitro+propagation+and+differentiation+of+cultures+of+the+intramolluscan+stages+of+the+human+parasite+Schistosoma+mansoni%5BTitle%5D)+AND+%22Proc.+Natl.+Acad.+Sci.+USA%22%5BJournal%5D)">Continuous in vitro propagation and differentiation of cultures of the intramolluscan stages of the human parasite Schistosoma mansoni.</a> Proc. Natl. Acad. Sci. USA. 96, 4965-4970 (1999).</li>
<li>Yoshino, T. P., Bayne, C. J., Bickham, U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molluscan+cells+in+culture%3A+primary+cell+cultures+and+cell+lines%5BTitle%5D)+AND+%22Can.+J.+Zool%22%5BJournal%5D)">Molluscan cells in culture: primary cell cultures and cell lines.</a> Can. J. Zool. 91, 391-404 (2013).</li>
<li>Coustau, C., Yoshino, T. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Flukes+without+snails%3A+Advances+in+the+in+vitro+cultivation+of+intramolluscan+stages+of+trematodes%5BTitle%5D)+AND+%22Exp.+Parasitol%22%5BJournal%5D)">Flukes without snails: Advances in the in vitro cultivation of intramolluscan stages of trematodes.</a> Exp. Parasitol. 94, 62-66 (2000).</li>
<li>Milligan, J. N., Jolly, E. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cercarial+transformation+and+in+vitro+cultivation+of+Schistosoma+mansoni+schistosomules%5BTitle%5D)+AND+%22J.+Vis.+Exp%22%5BJournal%5D)">Cercarial transformation and in vitro cultivation of Schistosoma mansoni schistosomules.</a> J. Vis. Exp. (54), e3191(2011).</li>
<li>Basch, P. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cultivation+of+Schistosoma+mansoniin+vitro.+II+production+of+infertile+eggs+by+worm+pairs+cultured+from+cercariae%5BTitle%5D)+AND+%22J.+Parasitol%22%5BJournal%5D)">Cultivation of Schistosoma mansoniin vitro. II production of infertile eggs by worm pairs cultured from cercariae.</a> J. Parasitol. 67 (2), 186-190 (1981).</li>
</ol>

Authors have nothing to disclose.

Miracidia of S. mansoni, isolated and manipulated as described herein, can infect only the snail intermediate host, and therefore do not represent a human biohazard during this phase of larval development. However, to avoid accidental exposure/infection of snails, care should be taken to perform miracidial isolations in a different location from areas where susceptible Biomphalaria snail species may be present or maintained. A separate room, registered as BSL2 space, is highly recommended. In addition, ...

The human blood flukes Schistosoma spp., are the causative agents of schistosomiasis, a neglected tropical disease afflicting an estimated 230 million people worldwide1. The most widespread species, Schistosoma mansoni, is geographically distributed in South America, the Caribbean archipelago, the Middle East and sub-Saharan Africa2. The life cycle of S. mansoni, and other schistosomes, is complex, involving a mammalian definitive host and freshwater snails of the genus Biomphalaria that serve as obligate intermediate hosts.
S. mansoni male and female adult worm pairs living in the posterior mesenteric veins of the mammalian host reproduce, resulting in the release of embryonated eggs (ova) that become lodged in the small venules of the intestinal mucosa. Eggs then breaks through the vessel walls, migrate through mucosal tissue, and eventually enter the intestinal lumen where they are voided with the feces. When ova enter freshwater and free-swimming larvae (miracidia) hatch, they must, in short order, find a suitable Biomphalaria snail to infect in order to continue its life cycle. This infection process involves miracidial attachment to the snail&#39;s outer body surface followed by active penetration and entry of the larva into the host. Soon after entry, the miracidium begins to shed its outer ciliated epidermal plates as it forms a syncytium that will become the new outer surface (tegument) of the next larval stage, the primary or mother sporocyst. Through asexual reproduction, each primary sporocyst produces and releases a second generation of sporocysts, termed secondary or daughter sporocysts, which in turn, generate and release large numbers of the final intramolluscan stage, the cercaria3. Upon escape from the snail host, free-swimming cercariae are capable of attaching to and directly penetrating the skin of a human or other suitable mammalian host. Upon entry into their new host, cercariae transform to the parasitic schistosomula stage and invade the vascular system. They, in turn, migrate to the lung and then to the hepatic vein where they mature to adult worms, form male and female pairs and travel to the mesenteric veins to complete their life cycle.
Successful intramolluscan or &#34;snail phase&#34; development of larval schistosomes is essential to continuation of the cycle of human host-to-host transmission. Of critical importance is the period following entry of the free-swimming miracidium into the snail host and its early transformation to the primary sporocyst stage. Depending on the physiological and immunological compatibility between host and parasite, it is during this phase of larval development that initial success or failure to establish infections is determined4,5,6. Subsequent development of primary sporocysts capable of asexually producing secondary sporocysts, which then generate human-infective cercariae, further require a permissive physiological host environment that provides for all of the parasite&#39;s growth and reproductive needs.
To date, little is known about the underlying physiological, biochemical and molecular processes controlling schistosome-snail interactions, especially the molecules and pathways involved in regulating larval development and reproduction, or modulating host immune responses. Ready access to large numbers of these larval stages under in vitro culture conditions that permit experimental manipulation would greatly facilitate the discovery of developmental pathways and underlying mechanisms of cell growth, differentiation and reproduction. Critical parasite pathways or mechanisms, identified through in vitro experimentation, could then be used to disrupt larval growth/reproduction in the snail host, or to identify snail host immune mechanisms involved in recognition and elimination of miracidial or sporocyst stages.
In this article and video presentation, we provide a detailed description of a method for isolating large numbers of free-swimming S. mansoni miracidia for introduction into in vitro culture that may then be subjected to follow-up experimental manipulation (see Figure 1 for a schematic overview of the protocol workflow). Although similar procedures have been described previously7,8,9, we felt that a detailed protocol would be useful to researchers who wish to employ this model to address still unanswered questions related to intramolluscan larval development, cellular proliferation, and schistosome-snail immune interactions. In addition, this approach could easily be adapted for isolation of eggs from other medically important trematodes such as bladder-dwelling S. haematobium, liver flukes or lung flukes.

<table><tbody><tr><td>&lt;strong&gt;Chernin&#039;s balanced salt solution (CBSS+)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;For 1L of solution&lt;/strong&gt;</td></tr><tr><td>2.8 g sodium chloride</td><td>Fisher Scientific</td><td>S271-3</td><td>Dissolve salts, except calcium chloride, and&amp;nbsp;</td></tr><tr><td>0.15 g of potassium chloride&amp;nbsp;</td><td>Sigma-Aldrich</td><td>P5405</td><td>sugars in 800 mL ddH2O</td></tr><tr><td>0.07 g sodium phosphate, dibasic anhydrous</td><td>Fisher Scientific</td><td>S374-500</td><td>Dissolve calcium chloride separately in 200&amp;nbsp;</td></tr><tr><td>0.45 g magnesium sulfate heptahydrate&amp;nbsp;</td><td>Sigma-Aldrich</td><td>M1880</td><td>mL ddH2O</td></tr><tr><td>0.53 g calcium chloride dihydrate&amp;nbsp;</td><td>Mallinckrodt</td><td>4160</td><td>Slowly add calcium soln to the salt/sugar soln with&amp;nbsp;</td></tr><tr><td>0.05 g sodium bicarbonate&amp;nbsp;&amp;nbsp;</td><td>Fisher Scientific</td><td>S233-3</td><td>with constant mixing</td></tr><tr><td>1 g glucose</td><td>MP Biomedicals</td><td>152527</td><td>Adjust to pH 7.2 and filter sterilize using a&amp;nbsp;</td></tr><tr><td>1 g trehalose</td><td>Sigma-Aldrich</td><td>T0167</td><td>0.22 &amp;micro;m disposable bottle-top filter</td></tr><tr><td>10 mL 100X penicillin/streptomycin</td><td>Hyclone</td><td>SV30010</td><td>Add filtered penicillin and streptomycin soln&amp;nbsp;&lt;br/&gt; prior use</td></tr><tr><td>&lt;strong&gt;Incomplete Bge&amp;nbsp; medium (Ibge)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;For 900 mL solution&lt;/strong&gt;</td></tr><tr><td>220 mL Schneider&amp;rsquo;s Drosophila medium modified</td><td>Lonza</td><td>04-351Q</td><td>Mix Schneider&#039;s medium with 680 mL ddH2O</td></tr><tr><td>4.5 g lactalbumin enzymatic hydrolysate</td><td>Sigma-Aldrich</td><td>L9010</td><td>Add lactalbumin hydrolysate and galactose</td></tr><tr><td>1.3 g galactose</td><td>Sigma-Aldrich</td><td>G0625</td><td>Adjust to pH 7.2 and filter sterilize using a 0.22 &amp;micro;m&lt;br/&gt; pre-sterilized disposable bottle-top filter</td></tr><tr><td>&lt;strong&gt;Complete Bge medium (cBge)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;For 100 mL of solution&lt;/strong&gt;</td></tr><tr><td>90 mL Incomplete Bge medium</td><td></td><td></td><td>To heat-inactivate FBS: Incubate thawed FBS in&amp;nbsp;</td></tr><tr><td>9 mL heat-inact. fetal bovine serum (FBS) (Optima)</td><td>Atlanta Biologicals</td><td>S12450</td><td>waterbath at 60&amp;deg;C for 1 hr while gently&amp;nbsp;</td></tr><tr><td>1 mL 100X penicillin/streptomycin</td><td>Hyclone</td><td>SV30010</td><td>swirling the bottle every 10 min&lt;br/&gt; Aliquot heat-inactivated FBS into 15-mL tubes&amp;nbsp;&lt;br/&gt; and store at -20&amp;deg;C.&amp;nbsp; Mix medium + FBS and&lt;br/&gt; filter sterilize using a 0.22 &amp;micro;m pre-sterilized&amp;nbsp;&lt;br/&gt; disposable bottle-top filter&amp;nbsp;&lt;br/&gt; Add penicillin and streptomycin prior to use</td></tr><tr><td>&lt;strong&gt;Pond water (stock solution)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;1L of stock solution&lt;/strong&gt;</td></tr><tr><td>12.5 g calcium carbonate</td><td>Fisher Scientific</td><td>C64-500</td><td>Mix all salts in 1L of ddH2O</td></tr><tr><td>1.25 g magnesium carbonate</td><td>Fisher Scientific</td><td>M27-500</td><td>Note that the salts will not have completely&amp;nbsp;</td></tr><tr><td>1.25 g&amp;nbsp; sodium chloride</td><td>Fisher Scientific</td><td>S271-3</td><td>dissolved.&amp;nbsp; Shake vigorously to suspend&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;</td></tr><tr><td>0.25 g&amp;nbsp; potassium chloride</td><td>Sigma-Aldrich</td><td>P5405</td><td>salts prior to making the working soln&amp;nbsp;&amp;nbsp;</td></tr><tr><td>&lt;strong&gt;Pond water (working solution)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;1.5L of solution&lt;/strong&gt;</td></tr><tr><td>0.8 mL stock solution pond water (shake prior use) in&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;</td><td></td><td></td><td>Mix stock to ddH2O</td></tr><tr><td>1500 mL of ddH2O</td><td></td><td></td><td>Sterilize pond water by autoclaving (slow&amp;nbsp;cycle)</td></tr><tr><td>1.5 mL of 100X penicillin/streptomycin&amp;nbsp;</td><td>Hyclone</td><td>SV30010</td><td>Add penicillin and streptomycin prior use</td></tr><tr><td>&lt;strong&gt;Saline solution (1.2% NaCl)&lt;/strong&gt;</td><td></td><td></td><td>&lt;strong&gt;1.5L of solution&lt;/strong&gt;</td></tr><tr><td>18 g sodium chloride in 1500 mL of ddH2O</td><td>Fisher Scientific</td><td>S271-3</td><td>Autoclave saline solution to sterilize</td></tr><tr><td>1.5 mL of 100X penicillin/ streptomycin</td><td>Hyclone</td><td>SV30010</td><td>Add penicillin and streptomycin prior use</td></tr><tr><td>&lt;strong&gt;Additional equipment and material:&amp;nbsp;&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>7-L mouse euthanizing chamber</td><td></td><td></td><td>Following approved IACUC protocol no. V001551</td></tr><tr><td>Mice</td><td>Taconic Biosciences</td><td></td><td>Swiss-Webster, female, 6-wk old, murine&amp;nbsp;&amp;nbsp;</td></tr><tr><td>CO&lt;sub&gt;2&lt;/sub&gt; tank and regulator</td><td></td><td></td><td>pathogen-free</td></tr><tr><td>24-well tissue culture plate</td><td>TPP</td><td>92424</td><td></td></tr><tr><td>1-L volumetric flasks</td><td></td><td></td><td></td></tr><tr><td>Light source (150W)</td><td>Chiu Tech Corp</td><td>Model F0-150</td><td></td></tr><tr><td>Centrifuge, refrigerated, swinging bucket</td><td>Eppendorf</td><td>Model 5810R</td><td></td></tr><tr><td>Centrifuge bottles (250 mL)</td><td>Nalgene</td><td></td><td></td></tr><tr><td>15-mL centrifuge tubes, sterile</td><td>Corning</td><td>430053</td><td></td></tr><tr><td>Sterile disposable transfer pipets&amp;nbsp;</td><td>Fisher Scientific</td><td>1371120</td><td></td></tr><tr><td>0.22 &amp;micro;m pre-sterilized disposable bottle-top filter&amp;nbsp;</td><td>EMD Millipore</td><td>SCGPS05RE</td><td></td></tr><tr><td>Stainless steel blender</td><td>Waring Commercial</td><td>Model 51BL31</td><td></td></tr><tr><td>Blender cup, 100 mL capacity</td><td>Waring Commercial</td><td></td><td></td></tr><tr><td>Inverted compound microscope</td><td>Nikon Instruments&amp;nbsp;</td><td>Eclipse TE300</td><td></td></tr></tbody></table>

mass isolation and in vitro cultivation of intramolluscan stages of the human blood fluke schistosoma mansoni

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Human blood flukes, Schistosoma spp., have a complex life cycle that involves asexual and sexual developmental phases within a snail intermediate and mammalian final host, respectively. The ability to isolate and sustain the different life cycle stages under in vitro culture conditions has greatly facilitated investigations of the cellular, biochemical and molecular mechanisms regulating parasite growth, development and host interactions. Transmission of schistosomiasis requires asexual reproduction and development of multiple larval stages within the snail host; from the infective miracidium, through primary and secondary sporocysts, to the final cercarial stage that is infective to humans. In this paper we present a step-by-step protocol for mass hatching and isolation of Schistosoma mansoni miracidia from eggs obtained from livers of infected mice, and their subsequent introduction into in vitro culture. It is anticipated that the detailed protocol will encourage new researchers to engage in and broaden this important field of schistosome research.

The vast majority of miracidia typically will have been collected in the first two "harvests". Incubation of isolated miracidia in CBSS+ triggers the miracidium-to-sporocyst transformation process (Figure 4A-C). Within the first hour following transfer to culture wells containing CBSS+, the majority of miracidia cease swimming (Figure 4A). At 6 h in culture, miracidia are in the process of actively shedding their...

This article describes a protocol for the large-scale axenic isolation and collection of free-swimming miracidia of the human blood fluke Schistosoma mansoni and their subsequent processing for introduction into in vitro culture.

Human blood flukes, Schistosoma spp., have a complex life cycle that involves asexual and sexual developmental phases within a snail intermediate and ...

mass-isolation-vitro-cultivation-intramolluscan-stages-human-blood

Research

JoVE Journal

Developmental Biology

We describe an in vitro method for culturing schistosomula of the flatworm parasite Schistosoma mansoni, via the harvesting and transformation of infective cercariae from the fresh water snail intermediate host Biomphalaria glabrata.

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Schistosoma mansoni eggs are potent stimulators of the T helper type 2 (Th2) immune response, characteristic of parasite infection, asthma and allergic inflammation. This protocol utilizes S. mansoni egg injection to generate a CD4 Th2 cytokine-induced inflammatory response in the lung, characterized by lung granuloma formation around the egg, eosinophilia and macrophage alternative activation.

Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation

We have developed an in vitro malaria-HIV-1 co-infection model to study the impact of Plasmodium falciparum on the HIV-1 replicative cycle in human primary monocyte-derived macrophages. This versatile system can easily be adapted to other primary cell types susceptible to HIV-1 infection.

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Heligmosomoides polygyrus is a murine nematode with powerful immunomodulatory capabilities that closely resemble those of highly-prevalent human helminth infection. Here we describe a protocol for the long-term maintenance of the H. polygyrus lifecycle.

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

We describe here the latest advances in viral isolation for the characterization of new genotypes of Faustovirus, a new asfarvirus-related lineage of giant viruses. This protocol can be applied to the high throughput isolation of viruses, especially giant viruses infecting amoeba.

A Rapid Strategy for the Isolation of New Faustoviruses from Environmental Samples Using Vermamoeba vermiformis

We describe a mouse model of experimental cerebral malaria and show how inflammatory and microvascular pathology can be tracked in vivo using magnetic resonance imaging.

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Here, we present a protocol to describe extracellular vesicles (EVs) isolation in in vitro cultured medium from adult Schistosoma japonicum.

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Here, we provided a method to achieve stable transfection of chicken Eimeria parasites by nucleofecting sporozoites or second-generation merozoites. Genetically modified eimerian parasites expressing heterologous antigenic genes could be used as vaccine delivery vehicles.

Nucleofection and In Vivo Propagation of Chicken Eimeria Parasites

Using focused ion beam milling to produce vitreous on-grid lamellae from plunge frozen biological samples for cryo-electron tomography.

Preparing Lamellae from Vitreous Biological Samples Using a Dual-Beam Scanning Electron Microscope for Cryo-Electron Tomography

We describe a rapid transient transduction technique in different developmental stages of Echinococcus granulosus using third-generation lentiviral vectors.

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Here, we describe in vitro culture conditions, isolation, and increased generation of extracellular vesicles (EVs) from Echinococcus granulosus. The small EVs were characterized by dynamic light scattering and transmission electron microscopy. The uptake by bone marrow-derived dendritic cells and their phenotypic modulation were studied using confocal microscopy and flow cytometry.

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Learn mass isolation and in vitro cultivation of Schistosoma mansoni miracidia using a mouse model. This protocol enables large-scale larval harvesting for advancing schistosomiasis research and disease control.

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Explore More Videos